1 |
Li X, Liu Y, Zheng S, Zhang T, Wu J, Sun Y, Zhang J, Liu G. Role of exosomes in the immune microenvironment of ovarian cancer. Oncol Lett 2021;21:377. [PMID: 33777201 DOI: 10.3892/ol.2021.12638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
2 |
Terlikowska KM, Dobrzycka B, Terlikowski SJ. Chimeric Antigen Receptor Design and Efficacy in Ovarian Cancer Treatment. Int J Mol Sci 2021;22:3495. [PMID: 33800608 DOI: 10.3390/ijms22073495] [Reference Citation Analysis]
|
3 |
Dawoud MM, Aiad HAES, Tawfiq EAE, Al-Qalashy FSA, Eissa N, El-Rebey HS. Role of SIX1, EYA2, and E-cadherin in ovarian carcinoma. Evidence on epithelial-mesenchymal transition from an immunohistochemical study. Ann Diagn Pathol 2021;55:151815. [PMID: 34534789 DOI: 10.1016/j.anndiagpath.2021.151815] [Reference Citation Analysis]
|
4 |
Liu L, Zhou Y, Dong X, Li S, Cheng S, Li H, Li Y, Yuan J, Wang L, Dong J, Li X. HOTAIRM1 Maintained the Malignant Phenotype of tMSCs Transformed by GSCs via E2F7 by Binding to FUS. Journal of Oncology 2022;2022:1-14. [DOI: 10.1155/2022/7734413] [Reference Citation Analysis]
|
5 |
An Y, Wang X, Wu X, Chen L, Yang Y, Lin X, Wang N, Duan J, Long S, Zhao X. Oncolytic reovirus induces ovarian cancer cell apoptosis in a TLR3-dependent manner. Virus Res 2021;301:198440. [PMID: 33940002 DOI: 10.1016/j.virusres.2021.198440] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|